AdamMBrufskyMD

PubMed

• Treatment outcomes in older patients with metastatic breast cancer receiving palbociclib plus an aromatase inhibitor: a plain language summary.
  Xianchen Liu, Benjamin Li, Lynn McRoy, Connie Chen, Adam Brufsky, Rachel M Layman, Hope S Rugo> ;Future Oncology. 2024 Mar 27
• Prolonging the lives of African-Americans with metastatic breast cancer by adding palbociclib to an aromatase inhibitor in routine clinical practice: a plain language ...
  Xianchen Liu, Benjamin Li, Lynn McRoy, Connie Chen, Tiah Tomlin-Harris, Hope S Rugo, Rachel M Layman, Adam Brufsky> ;Future Oncology. 2024 Mar 22
• Health-related quality of life over chemotherapy course among individuals with early-stage breast cancer: the association of social determinants of health and neighbor...
  Kai-Lin You, Susan M Sereika, Catherine M Bender, Jill B Hamilton, Susan R Mazanec, Adam Brufsky, Margaret Quinn Rosenzweig> ;Supportive Care in Cancer. 2024 Mar 12
• Final Results From the Randomized Phase III ASCENT Clinical Trial in Metastatic Triple-Negative Breast Cancer and Association of Outcomes by Human Epidermal Growth Fac...
  Aditya Bardia, Hope S Rugo, Sara M Tolaney, Delphine Loirat, Kevin Punie, Mafalda Oliveira, Adam Brufsky, Kevin Kalinsky, Javier Cortés, Joyce O' Shaughnessy, Véroniqu...> ;Journal of Clinical Oncology. 2024 Feb 29
• Breast Cancer Index and Prediction of Extended Aromatase Inhibitor Therapy Benefit in Hormone Receptor-positive Breast Cancer from the NRG Oncology/NSABP B-42 Trial.
  Eleftherios P Mamounas, Hanna Bandos, Priya Rastogi, Yi Zhang, Kai Treuner, Peter C Lucas, Charles E Geyer, Louis Fehrenbacher, Stephen K Chia, Adam M Brufsky, Janice ...> ;Clinical Cancer Research. 2024 Feb 20
• Entinostat, nivolumab and ipilimumab for women with advanced HER2-negative breast cancer: a phase Ib trial.
  Roussos Torres, E., Ho, W., Danilova, L., Tandurella, J., Leatherman, J., Rafie, C., Wang, C., Brufsky, A., LoRusso, P., Chung, V., Yuan, Y., Downs, M., O'Connor, A., ...> ;Nature Cancer. 2024 Feb 14
• Long-Term Follow-Up of the Anthracyclines in Early Breast Cancer Trials (USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 [NRG Oncology]).
  Geyer, C., Blum, J., Yothers, G., Asmar, L., Flynn, P., Robert, N., Hopkins, J., O'Shaughnessy, J., Rastogi, P., Puhalla, S., Hilton, C., Dang, C., Gómez, H., Vukelja,...> ;Journal of Clinical Oncology. 2024 Feb 9
• Activity and safety of enobosarm, a novel, oral, selective androgen receptor modulator, in androgen receptor-positive, oestrogen receptor-positive, and HER2-negative a...
  Carlo Palmieri, Hannah Linden, Stephen N Birrell, Sally Wheelwright, Elgene Lim, Lee S Schwartzberg, Amy R Dwyer, Theresa E Hickey, Hope S Rugo, Patrick Cobb, Joyce A ...> ;The Lancet. Oncology. 2024 Mar 1
• Poziotinib treatment in patients with HER2-positive advanced breast cancer who have received prior anti-HER2 regimens.
  Marti, J., Lathrop, K., Leu, S., Bhat, G., Nasrazadani, A., Restrepo, A., Brufsky, A.> ;Breast Cancer Research and Treatment. 2024 Jan 23
• Omission of surgery, primary endocrine therapy adherence, and effect of comorbidity in older women with estrogen receptor positive breast cancer.
  Neil Carleton, Hira Abidi, Susrutha Puthanmadhom-Narayanan, Oscar C Marroquin, Steffi Oesterreich, Emilia J Diego, Adam M Brufsky, Adrian V Lee, Priscilla F McAuliffe> ;Journal of Geriatric Oncology. 2024 Apr 1
• The Effect of Race and Area Deprivation on Symptom Profiles over the Course of Early-Stage Breast Cancer.
  Abujaradeh, H., O'Brien, J., Mazanec, S., Bender, C., Schlemmer, I., Nasrollahi, E., Rosenzweig, M., Brufsky, A.> ;Research Square. 2023 Nov 28
• Palbociclib Combined with an Aromatase Inhibitor in Patients with Breast Cancer with Lung or Liver Metastases in US Clinical Practice.
  Adam Brufsky, Xianchen Liu, Benjamin Li, Lynn McRoy, Connie Chen, Rachel M Layman, Hope S Rugo> ;Cancers. 2023 Nov 2
• Effects of socioeconomic status and race on survival and treatment in metastatic breast cancer.
  Susrutha Puthanmadhom Narayanan, Dianxu Ren, Steffi Oesterreich, Adrian V Lee, Margaret Q Rosenzweig, Adam M Brufsky> ;NPJ Breast Cancer. 2023 Nov 1
• Real-world treatment patterns for palbociclib plus an aromatase inhibitor, or an aromatase inhibitor alone, for patients with metastatic breast cancer in the Flatiron ...
  Hope S Rugo, Xianchen Liu, Benjamin Li, Lynn McRoy, Connie Chen, Rachel M Layman, Adam Brufsky> ;International Journal of Cancer. 2024 Feb 15
• 2 citations
  Twenty-Year Follow-Up of a Phase II Trial of Taxotere/Carboplatin/Herceptin in Patients With Metastatic HER2-Positive Breast Cancer.
  Juan Luis Gomez Marti, Azadeh Nasrazadani, Ying Ding, Daniel Normolle, Adam M Brufsky> ;The Oncologist. 2023 Nov 2
• Real-World Effectiveness of Palbociclib Plus Aromatase Inhibitors in African American Patients With Metastatic Breast Cancer.
  Hope S Rugo, Xianchen Liu, Benjamin Li, Lynn McRoy, Connie Chen, Rachel M Layman, Adam Brufsky> ;The Oncologist. 2023 Oct 3
• Erratum to Metaplastic Breast Carcinoma: A Clinical-Pathologic Study of 97 Cases With Subset Analysis of Response to Neoadjuvant Chemotherapy [Modern Pathology 32(6) (...
  Min Han, Arsalan Salamat, Li Zhu, Huina Zhang, Beth Z Clark, David J Dabbs, Gloria J Carter, Adam M Brufsky, Rachel C Jankowitz, Shannon L Puhalla, Ronald R Johnson, A...> ;Modern Pathology. 2023 Aug 1
• Predicting clinical benefit from continuation of cyclin dependent kinase (CDK) 4/6 inhibitors beyond progression.
  Julia Foldi, Adam Brufsky> ;Annals of Translational Medicine. 2023 Jun 30
• 2 citations
  Persistence to extended adjuvant endocrine therapy following Breast Cancer Index (BCI) testing in women with early-stage hormone receptor-positive (HR +) breast cancer.
  Julia Foldi, Anastasia Tsagianni, Max Salganik, Catherine A Schnabel, Adam Brufsky, G J van Londen, Lajos Pusztai, Tara Sanft> ;BMC Cancer. 2023 Jun 30
• 1 citations
  The feasibility, acceptability, and preliminary efficacy of a self-advocacy serious game for women with advanced breast or gynecologic cancer.
  Teresa Hagan Thomas, Catherine Bender, Heidi S Donovan, Patty Jo Murray, Sarah Taylor, Margaret Rosenzweig, Susan M Sereika, Adam Brufsky, Yael Schenker> ;Cancer. 2023 Oct 1
• 5 citations
  Ten-year update: NRG Oncology/National Surgical Adjuvant Breast and Bowel Project B-42 randomized trial: extended letrozole therapy in early-stage breast cancer.
  Eleftherios P Mamounas, Hanna Bandos, Priya Rastogi, Barry C Lembersky, Jong-Hyeon Jeong, Charles E Geyer Jr, Louis Fehrenbacher, Stephen K Chia, Adam M Brufsky, Janic...> ;Journal of the National Cancer Institute. 2023 Nov 8
• P-REALITY X: A Real-World Analysis of Palbociclib Plus an Aromatase Inhibitor in HR+/HER2- Metastatic Breast Cancer-A Podcast.
  Adam Brufsky, Christopher Gallagher> ;Targeted Oncology. 2023 May 1
• 2 citations
  A Gene Panel Associated With Abemaciclib Utility in-Mutated Breast Cancer After Prior Cyclin-Dependent Kinase 4/6-Inhibitor Progression.
  Jamie O Brett, Taronish D Dubash, Gabriela N Johnson, Andrzej Niemierko, Veronica Mariotti, Leslie S L Kim, Jing Xi, Apurva Pandey, Siobhan Dunne, Azadeh Nasrazadani, ...> ;JCO Precision Oncology. 2023 May 1
• 3 citations
  Real-world comparative effectiveness of palbociclib plus letrozole versus letrozole in older patients with metastatic breast cancer.
  Hope S Rugo, Xianchen Liu, Benjamin Li, Lynn McRoy, Rachel M Layman, Adam Brufsky> ;Breast. 2023 Jun 1
• 2 citations
  Long-term outcomes of dual vs single HER2-directed neoadjuvant therapy in NSABP B-41.
  Priya Rastogi, Gong Tang, Saima Hassan, Charles E Geyer Jr, Catherine A Azar, Gustav C Magrinat, J Marie Suga, Harry D Bear, Luis Baez-Diaz, Shakir Sarwar, Jean-Franco...> ;Breast Cancer Research and Treatment. 2023 Jun 1
• Join now to see all

Journal Articles

• Molecular Mechanisms Linking High Body Mass Index to Breast Cancer Etiology in Post-Menopausal Breast Tumor and Tumor-Adjacent Tissues  
  Adam M Brufsky, Tari A King, Susan B Brown, Breast Cancer Research and Treatment
• Nab-Paclitaxel plus Carboplatin or Gemcitabine vs Gemcitabine plus Carboplatin as First-Line Treatment for Patients with Triple-Negative Metastatic Breast Cancer: Resu...  
  H Ali, A Brufsky, M Shtivelband, S Gluck, J Miller, R Young, Annals of Oncology
• Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer  
  Matthew P Goetz, Thomas J Saphner, Joseph A Sparano, Lynne I Wagner, Peter M Ravdin, Daniel F Hayes, Adam M Brufsky, Della F Makower, Sunil S Badve, Robert J Gray, Wil..., The New England Journal of Medicine

Lectures

• A Metastatic Breast Cancer Patient with Activating HER2 Exon 20 Insertion Mutation Responds to Poziotinib; A Case Report of Compassionate Drug Use 
  2019 ASCO Annual Meeting - 6/1/2019